Liver Failure Clinical Trials

A listing of Liver Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 209 clinical trials
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.

  • 60 views
  • 02 Feb, 2021
  • 6 locations
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

stroke severity, ages, comorbidity with hypertension, diabetes, heart failure, liver and kidney dysfunction and bleeding risks. Thus, the timing of the initiation of NOACs is yet to be further studied

diabetes
coagulation factor
stroke
heart failure
deficit
  • 13 views
  • 11 Feb, 2021
  • 1 location
NAFLD Primary Care

(e.g. alcohol and steatogenic drugs). It represents a broad spectrum of clinical entities from non-alcoholic fatty liver (NAFL) to advanced liver disease with hepatic failure. Most of the patients have

angina pectoris
diabetes
fatty liver
type 2 diabetes mellitus
fats
  • 0 views
  • 23 Jun, 2021
  • 1 location
A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound Viscoelasticity

related fundamental research and clinical practice. Therefore, this project plan to apply LOGIQ E viscoelastography machine as research tool, rat liver fibrosis model and rat liver failure model as

ascites
elastography
liver disease
fibrosis
biopsy of liver
  • 0 views
  • 10 Sep, 2021
  • 1 location
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

Treatment with Tenofovir Alafenamide(TAF) in Chronic Hepatitis B (CHB) patients classified as beyond treatment indication of current international guidelines (e.g. aged more than 40 years old and 4 log HBV-DNA IU/mL < 8) is expected to bring improvement in long-term clinical outcomes. This expected result may expand the treatment indications …

hepatitis b antigen
tenofovir
ml 7
hepatitis b e antigen
cirrhosis
  • 0 views
  • 25 Apr, 2021
  • 1 location
Precision Medicine for Prediction & Prevention of Early Pre-eclampsia

This study aims to evaluate the feasibility of implementing a clinical model for precision screening of early pre-eclampsia into the current prenatal screening service at Sunnybrook Health Sciences Center (SHSC).

  • 0 views
  • 30 Mar, 2021
  • 1 location
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients

Early treatment of invasive fungal infections (IFI) may prevent undue mortality in acute on chronic liver failure (ACLF) patients. We aim to study the impact of early empiric treatment (based on

acute renal failure
invasive fungal infection
antibacterial agents
tuberculosis
prophylaxis
  • 0 views
  • 21 Mar, 2021
  • 1 location
Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients

approximately 40 acute or acute-on-chronic liver failure patients.

international normalized ratio
liver transplant
chronic liver failure
acute on chronic liver failure
hepatic failure
  • 4 views
  • 24 Jan, 2021
  • 1 location
Pyrophosphate Homeostasis and Hepatic Expression of ABCC6.Pyro-TH

performed in the treatment of chronic liver failure (Child B or C) or, in the absence of liver failure, in the treatment of hepatocellular carcinoma. By measuring[PPi]pl before transplantation and after

carcinoma
deficit
calcium
liver transplant
  • 3 views
  • 22 Jan, 2021
  • 1 location
Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment

The primary purpose of this study is to evaluate the effect of hepatic impairment on the systemic pharmacokinetics, safety, and tolerability of icenticaftor in participants with varying degrees of hepatic impairment.

hepatic impairment
liver disease
  • 0 views
  • 12 Aug, 2021
  • 2 locations